2873 Stories, most recent news story added Thu Jul 16, 6:52 pm ET
People with a gene variant that sharply increases the risk of Alzheimer's disease in old age may show memory impairment earlier than thought -- sometimes well before their 60th birthday, according to new study in the New England Journal of Medicine.
People with the "Alzheimer's gene" begin to have memory declines tied to aging before they reach 60, even if they have no clinical symptoms of dementia, a U.S. research team reported on Wednesday.
Nonsteroidal anti-inflammatory drugs like naproxen may help prevent Alzheimer's disease.
Title: Alzheimer's Gene Test: No Harm? Category: Health News Created: 7/16/2009 Last Editorial Review: 7/16/2009
Title: New Treatments for Alzheimer's on the Horizon Category: Health News Created: 7/16/2009 7:00:00 AM Last Editorial Review: 7/16/2009
Adult children who have a parent with Alzheimer's disease may want to know if they carry a gene that raises their risk of getting the mind-robbing disease. But can they handle the test result, psychologically? Findings from a study released today hint that most can handle the information.
When people learn they are predisposed to Alzheimer's disease, any depression or anxiety is not long lasting, a new study indicates.These findings help address a longstanding debate about whether learning such information might cause lasting psychological harm, at least among those with a family history of Alzheimer's disease, says Scott Roberts, a University of Michigan researcher at the School ...
WEDNESDAY, July 15 (HealthDay News) -- Giving scientists insight into the origins of a devastating illness, new research suggests that people with a genetic propensity to develop Alzheimer's disease start experiencing memory loss as early as their 50s.
People who learn through genetic testing that they have a higher than average risk for Alzheimer's disease are able to handle the bad news pretty well, results from the first major study of this suggest.
Researchers have shown that disclosing genetic risk information to adult children of patients with Alzheimer's disease who request this information does not result in significant short-term psychological distress.
Barrow Neurological Institute researchers have identified a novel receptor in the brain that is extremely sensitive to beta-amyloid peptide and may play a key role in early stages of Alzheimer's disease.
Medivation's dimebon may help Alzheimer's patients--but scientists aren't sure how.
A small study finds that even when a genetic test for a link to Alzheimer’s disease is positive, people are not distressed.
Researchers from Boston University School of Medicine (BUSM) have shown that disclosing genetic risk information to adult children of patients with Alzheimer's disease (AD) who request this information does not result in significant short-term psychological distress.
Adult children of Alzheimer's disease patients don't suffer psychological distress when told they carry a gene that increases their risk of the disease, researchers report Thursday.
Five thousand dollars has been awarded to Texas Tech Health Sciences Center in Amarillo from the Alzheimer's Foundation of America.
If you are a proponent of the early detection of Alzheimer's ...
If you missed The Alzheimer's Project -- the multi-part HBO ...
It's only about six weeks before scheduled Committee votes ...
First of all, I want to apologize to everyone who reads this site ...
We already know that Vitamin D is essential for maintaining bone ...
Maybe. Dr. Thomas B. Shea of the Center for Cellular Neurobiology ...
Open slideshowReuters
Open slideshowAFP/File
Open slideshowAFP/File
Open slideshowAFP/File
